Kun Song

机构：Fujian Medical University, Central South University, Palo Alto University, First People's Hospital of Foshan, First Affiliated Hospital of Fujian Medical University, Stanford Medicine, Xiangya Hospital Central South University, Stanford University · ORCID：0000-0003-3822-2891

发表论文 66 篇 · 总被引 1942 次 · h-index 25

代表论文

• Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China (2024 · The Lancet · 被引 111)
• Targeting TCF19 sensitizes MSI endometrial cancer to anti-PD-1 therapy by alleviating CD8+ T cell exhaustion via TRIM14-IFN-β axis (2023 · Cell Reports · 被引 33)
• Clarifying the effect of gut microbiota on allergic conjunctivitis risk is instrumental for predictive, preventive, and personalized medicine: a Mendelian randomization analysis (2023 · The EPMA Journal · 被引 25)
• The lethal K18-hACE2 knock-in mouse model mimicking the severe pneumonia of COVID-19 is practicable for antiviral development (2024 · Emerging Microbes & Infections · 被引 21)
• TRPV1 inhibition suppresses non-small cell lung cancer progression by inhibiting tumour growth and enhancing the immune response (2023 · Cellular Oncology · 被引 14)
• Preoperative computed tomography-determined sarcopenia is a reliable prognostic factor in patients with gastric cancer after radical gastrectomy: A sex-specific analysis (2022 · Frontiers in Nutrition · 被引 14)